clinicaltrials.gov/ct2/show...
New clinical trial registered: InSightec has registered a two-arm, open-label study to establish safety & feasibility of intracerebral delivery of GCase (via MR-guided focused ultrasound) in 14 individuals with Parkinsons (7 GBA-PD & 7 iPD)
Official Title: A Phase I/II Study for Bilateral Putamenal Delivery of Recombinant Glucocerebrosidase in Patients With Parkinson's Disease Using MR-guided Focused Ultrasound Induced Opening of the Blood-brain Barrier
Estimated Study Completion Date: December 31, 2023
Intermittent Hypoxia for Parkinson's disease PD - Benefit or Harm
The MRIgFUS lesion shrinks. Who knew? Interview of Daphne Bryan following the publication of her book: “Parkinson’s and the B1 therapy”.
Parkinson's and Mitohormesis - presentation by Dr. Matthew CL Phillips
Uridine - from my experience..
